Jens-Otto Andreas - Head Statistical Sciences & Innovation - Bone & New Diseases at UCB Biosciences GmbH Lisa Comarella - Director Biostatistics at .. Read more CROS NT Giacomo Mordenti - Head of Biostatistics & Data Management Europe at Daiichi Sankyo Europe GmbH Marc Vandemeulebroecke - Global Group Head for Dermatology at Novartis Biostatistics. Introduction There is tremendous interest and excitement surrounding the application of Machine learning (ML) in drug development. Machine Learning (ML) tools can process information much faster, cheaper and more accurately than any human, and some people expect no less than a change to the clinical drug development paradigm. Any examples will be inspired by real problems. Type of training Shared presentation by Markus und Lorenz that aims to provide theoretical background and practical examples. Questions are welcome, we are hoping for lively discussions. Studies of mathematics at the Ruhr-University Bochum - Doctoral thesis at the Hannover medical school - More than 5 years of industry experience - Senior Principal Statistical Consultant at Novartis.
- Share your Experience